Experience of Thoracotomy and Robot-assisted Bronchial Sleeve Resection after Neoadjuvant Chemoimmunotherapy for Local Advanced Central Lung Cancer
Conclusion In patients with locally advanced central NSCLC after neoadjuvant chemoimmunotherapy can achieve the tumor reduction, tumor stage decline and increase the R0 resection rate, bronchial sleeve resection is safe and feasible. Under the premise of following the two principles of surgical safety and realizing the tumor R0 resection, robot-assisted bronchial sleeve resection can be preferred.
DOI: 10.3779/j.issn.1009-3419.2021.101.46
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research
More News: Bronchial Tumour | Cancer | Cancer & Oncology | China Health | Lung Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Non-Small Cell Lung Cancer | Pathology | Study | Thoracotomy